A vast array of studies have been conducted to understand the role of RKIP in various malignancies such as melanoma [1], prostate cancer [2], breast cancer [3], gastric cancer [4], glioblastoma [5], lung cancer [6], and myelogenous leukemia [7]. The gene discussed is PEBP1; the disease is prostate carcinoma.